Published in Clin Exp Immunol on July 01, 1990
"...those left behind." Biology and oncology of invasive glioma cells. Neoplasia (1999) 1.24
Augmentation of reverse arthus reaction by mast cells in mice. J Clin Invest (1991) 1.09
ICAM-1 (Lys469Glu) and PECAM-1 (Leu125Val) polymorphisms in diffuse astrocytomas. Clin Exp Med (2009) 0.88
Induction of ICAM-1 on human neural cells and mechanisms of neutrophil-mediated injury. Am J Pathol (1991) 0.83
Soluble intercellular adhesion molecule-1 for stable and acute phases of idiopathic pulmonary fibrosis. Springerplus (2015) 0.78
VEGFR-2 Expression in Glioblastoma Multiforme Depends on Inflammatory Tumor Microenvironment. Int J Inflam (2015) 0.75
Tumour necrosis factor-alpha induces an increase in susceptibility of human glioblastoma U87-MG cells to natural killer cell-mediated lysis. Br J Cancer (1994) 0.75
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem (1983) 206.01
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci U S A (1980) 109.70
Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol (1986) 10.92
Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell (1987) 9.41
T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature (1989) 9.29
Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med (1982) 8.74
A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol (1986) 7.71
The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Annu Rev Immunol (1987) 6.94
Neural cell adhesion molecule: structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing. Science (1987) 6.48
Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell (1988) 5.75
Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J Cell Biol (1988) 5.68
Adhesion molecules controlling lymphocyte migration. Cell (1989) 4.63
ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM. Nature (1988) 4.47
Tissue-specific expression of mouse alpha-amylase genes. J Mol Biol (1980) 4.30
Comparison of three actin-coding sequences in the mouse; evolutionary relationships between the actin genes of warm-blooded vertebrates. J Mol Evol (1986) 3.61
ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells. Nature (1988) 3.12
Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. J Immunol (1987) 3.06
Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol (1989) 2.77
Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells. Nature (1989) 2.61
Functional evidence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1-dependent adhesion in T cell-mediated cytotoxicity. Eur J Immunol (1988) 2.35
The amino acid sequences of the myelin-associated glycoproteins: homology to the immunoglobulin gene superfamily. J Cell Biol (1987) 1.87
Supergene families meet in the immune system. Immunol Today (1989) 1.78
Monoclonal antibody analysis of MHC expression in human brain biopsies: tissue ranging from "histologically normal" to that showing different levels of glial tumor involvement. J Immunol (1986) 1.40
Expression of 7F7-antigen, a human adhesion molecule identical to intercellular adhesion molecule-1 (ICAM-1) in human carcinomas and their stromal fibroblasts. Int J Cancer (1989) 1.31
Intratumoral LAK cell and interleukin-2 therapy of human gliomas. J Neurosurg (1989) 1.27
Lymphocyte hormone receptors. Annu Rev Immunol (1987) 1.26
Characterization of an established human malignant glioma cell line: LN-18. Acta Neuropathol (1981) 1.07
Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumors. Characterization of cell subsets with monoclonal antibodies. J Neurosurg (1984) 1.05
Cytokine gene expression during the generation of human lymphokine-activated killer cells: early induction of interleukin 1 beta by interleukin 2. Cancer Res (1989) 1.02
Astrocytes as antigen-presenting cells. Part II: Unlike H-2K-dependent cytotoxic T cells, H-2Ia-restricted T cells are only stimulated in the presence of interferon-gamma. J Neuroimmunol (1986) 0.97
Immunohistological and functional analyses of lymphoid infiltrates in human glioblastomas. Cancer Res (1988) 0.95
Prostaglandin and thromboxane synthesis by human intracranial tumors. Cancer Res (1989) 0.87
Astrocytes and intracerebral immune responses. J Clin Immunol (1989) 0.85
Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res (1994) 1.84
Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2. J Immunol (1989) 1.79
Human glioblastoma cells release interleukin 6 in vivo and in vitro. Cancer Res (1990) 1.70
Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. J Immunol (1984) 1.68
Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nat Genet (1994) 1.66
Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system. Cancer Res (1992) 1.51
Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J Clin Invest (1997) 1.43
Intraorbital ophthalmic artery aneurysm associated with basilar tip saccular aneurysm. Neuroradiology (2002) 1.43
Synovial cyst and degeneration of the transverse ligament: an unusual cause of high cervical myelopathy. Case report. J Neurosurg (1997) 1.42
Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis. J Exp Med (1997) 1.39
Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor. Oncogene (1999) 1.37
Management of primary intracranial germinomas: diagnostic surgery or radical resection? J Neurosurg (1997) 1.33
Stem cell studies of human malignant brain tumors. Part 1: Development of the stem cell assay and its potential. J Neurosurg (1983) 1.28
Long-term follow up of patients surgically treated by the far-lateral approach for foraminal and extraforaminal lumbar disc herniations. J Neurosurg (1999) 1.26
Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro. Int J Cancer (1994) 1.25
Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67. Neurosurgery (1988) 1.21
Endovascular coil placement compared with surgical clipping for the treatment of unruptured middle cerebral artery aneurysms: a consecutive series. J Neurosurg (1999) 1.08
The effects of midazolam reversal by RO 15-1788 on cerebral perfusion pressure in patients with severe head injury. Intensive Care Med (1988) 1.08
Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma. Oncogene (1999) 1.07
Thrombospondin-1 is downregulated by anoxia and suppresses tumorigenicity of human glioblastoma cells. J Exp Med (2000) 1.07
Characterization of an established human malignant glioma cell line: LN-18. Acta Neuropathol (1981) 1.07
Extreme lateral lumbar disc herniation. Br J Neurosurg (1987) 1.06
Aquaporin 1 and aquaporin 4 expression in human brain after subarachnoid hemorrhage and in peritumoral tissue. Acta Neurochir Suppl (2003) 1.06
Granulocyte-macrophage colony-stimulating factor (GM-CSF) production by glioblastoma cells. Despite the presence of inducing signals GM-CSF is not expressed in vivo. J Immunol (1992) 1.05
Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas. Oncogene (1998) 1.04
Meningiomas involving the anterior clinoid process. Br J Neurosurg (1994) 1.04
Cellular and tumoural heterogeneity of EGFR gene amplification in human malignant gliomas. Acta Neurochir (Wien) (1990) 1.04
Comparative localization of murine monoclonal antibody Me1-14 F(ab')2 fragment and whole IgG2a in human glioma xenografts. Cancer Res (1988) 1.04
The perianeurysmal environment: influence on saccular aneurysm shape and rupture. AJNR Am J Neuroradiol (2006) 1.04
Human glioma-associated antigens detected by monoclonal antibodies. Cancer Res (1981) 1.02
Demonstration of HLA-DR antigens in normal human brain. J Neurol Neurosurg Psychiatry (1984) 1.01
Traumatic aneurysm of the posterior inferior cerebellar artery: case report. Neurosurgery (1991) 1.01
Preoperative silk suture embolization of cerebral and dural arteriovenous malformations. Neurosurg Focus (2001) 1.00
Non-invasive epileptic focus localization using EEG-triggered functional MRI and electromagnetic tomography. Electroencephalogr Clin Neurophysiol (1998) 1.00
Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2. J Neurosurg (1989) 1.00
The glioblastoma-derived T-cell suppressor factor/transforming growth factor beta 2 inhibits the generation of lymphokine-activated killer (LAK) cells. Int J Cancer (1988) 0.99
Development of a cavernous malformation of the brain. AJNR Am J Neuroradiol (1998) 0.98
[Definition of apnea in the diagnosis of brain death]. Schweiz Med Wochenschr (1982) 0.98
In situ characterization, clonogenic potential, and antitumor cytolytic activity of T lymphocytes infiltrating human brain cancers. J Neurosurg (1988) 0.98
Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas. Cancer Res (1993) 0.96
Immunohistological and functional analyses of lymphoid infiltrates in human glioblastomas. Cancer Res (1988) 0.95
Malignant glioma: should chemotherapy be overthrown by experimental treatments? Ann Oncol (1998) 0.94
Extreme lateral lumbar disc herniation: clinical presentation in 178 patients. Acta Neurochir (Wien) (1994) 0.94
Therapeutic decision and management of aneurysmal subarachnoid haemorrhage based on computed tomographic angiography. Br J Neurosurg (2003) 0.94
Endovascular coiling compared with surgical clipping for the treatment of unruptured middle cerebral artery aneurysms: an update. Acta Neurochir Suppl (2002) 0.94
Presence of sex steroid hormone receptors in meningioma tissue. Surg Neurol (1981) 0.92
IL-6 stimulates growth and inhibits constitutive, protein synthesis-independent apoptosis of murine B-cell hybridoma 7TD1. Cell Immunol (1994) 0.92
Epilepsy in patients with central nervous system tumors. Curr Opin Neurol (1996) 0.91
Nonsurgical treatment of interhemispheric subdural empyemas. Helv Paediatr Acta (1979) 0.89
Identification of the putative brain tumor antigen BF7/GE2 as the (de)toxifying enzyme microsomal epoxide hydrolase. Cancer Res (2000) 0.89
Language representation in a patient with a dominant right hemisphere: fMRI evidence for an intrahemispheric reorganisation. Neuroreport (2001) 0.89
Immunoisolated xenogenic chromaffin cell therapy for chronic pain. Initial clinical experience. Anesthesiology (1996) 0.89
Chondromyxoid fibroma of the petrous-sphenoid junction. Surg Neurol (1987) 0.88
Characterization of four human malignant glioma cell lines. Acta Neuropathol (1985) 0.88
Phenotyping of 60 cultured human gliomas and 34 other neuroectodermal tumors by means of monoclonal antibodies against glioma, melanoma and HLA-DR antigens. Eur J Cancer Clin Oncol (1985) 0.88
Giant cell tumor of the orbit. Neurosurgery (1993) 0.88
Tuberothalamic infarct after division of a hypoplastic posterior communicating artery for clipping of a basilar tip aneurysm: case report. Neurosurgery (1991) 0.87
EEG-triggered functional MRI in patients with pharmacoresistant epilepsy. J Magn Reson Imaging (2000) 0.87
Expression of neuroectodermal antigens common to melanomas, gliomas, and neuroblastomas. I. Identification by monoclonal anti-melanoma and anti-glioma antibodies. Acta Neuropathol (1982) 0.87
Choroid plexus papilloma of the cerebellopontine angle presenting as a subarachnoid hemorrhage: case report. Neurosurgery (1984) 0.87
Cerebellar haematoma due to a cavernous angioma in a child. Acta Neurochir (Wien) (1982) 0.86
Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subset. Int Immunol (1999) 0.86
Sellar and parasellar extra-axial cavernous hemangiomas. Acta Neurochir (Wien) (1994) 0.86
Microsurgical anatomy and operative technique for extreme lateral lumbar disc herniations. Acta Neurochir (Wien) (1992) 0.86
Anterior inferior cerebellar artery aneurysm, carotid bifurcation aneurysm, and dural arteriovenous malformation of the tentorium in the same patient. Neurosurgery (1987) 0.85
Effects of propranolol on resting metabolic rate after severe head injury. Crit Care Med (1989) 0.85
Brain tumor-associated antigens. Prog Exp Tumor Res (1984) 0.85
Computed tomography of the postoperative intervertebral disc and lumbar spinal canal: investigation of twenty-five patients after successful operation for lumbar disc herniation. Neurosurgery (1988) 0.85
Expression of class II major histocompatibility antigens on reactive astrocytes and endothelial cells within the gliosis surrounding metastases and abscesses. J Neuroimmunol (1986) 0.85
Three-dimensional volume rendering for magnetic resonance angiography in the screening and preoperative workup of intracranial aneurysms. J Neurosurg (1996) 0.85
Differential expression of the CD44 molecule in human brain tumours. Int J Cancer (1992) 0.84
Absence of p53 gene mutations in a tumor panel representative of pilocytic astrocytoma diversity using a p53 functional assay. Int J Cancer (1998) 0.84
Phantom face: conscious correlate of neural reorganization after removal of primary sensory neurones. Neuroreport (1996) 0.84
Vagal schwannoma associated with syncopal attacks and postural hypotension: a case report. Neurosurgery (1990) 0.84
Leptomeningeal cyst in newborns due to vacuum extraction: report of two cases. Childs Nerv Syst (1996) 0.84
Activation and adhesion molecule expression on lymphoid infiltrates in human glioblastomas. J Neuroimmunol (1990) 0.84
Intracranial sarcoidosis presenting angiographically as a sub-dural hematoma. Surg Neurol (1978) 0.83
Recent advances in immunobiology of brain tumors. J Neurooncol (1993) 0.83
Hormonal and metabolic changes following severe head injury or noncranial injury. JPEN J Parenter Enteral Nutr (1989) 0.83
Hypotensive effect of nimodipine during treatment for aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) (1995) 0.83
Analysis of cytokine receptor messenger RNA expression in human glioblastoma cells and normal astrocytes by reverse-transcription polymerase chain reaction. J Neurosurg (1994) 0.83
Human glioblastoma cells produce 77 amino acid interleukin-8 (IL-8(77)). J Neurooncol (1993) 0.83
Developmental venous anomaly with an arteriovenous shunt and a thrombotic complication. Case report. J Neurosurg (2001) 0.82
Expression and release of interleukin-1 by human glioblastoma cells in vitro and in vivo. Acta Neurochir (Wien) (1993) 0.82